Bradda Head Lithium Ltd Announces Unaudited Interim Financial Statements

Rhea-AI Summary

Bradda Head Lithium Limited has released its unaudited condensed interim financial statements for the nine-month period ended November 30, 2022. The company reported a loss of US$3,074,862, compared to a loss of US$2,705,148 in the same period the previous year. General and administrative expenses surged to US$4,242,520, primarily due to increased contractor costs and share-based payments. Cash and cash equivalents rose to US$10,603,037, up from US$7,327,303 in February 2022. Total assets increased to US$19,584,569 from US$13,354,840. No impairment was recognized in exploration assets, and the company issued 73,195,560 warrants during the period.

Positive

• Increase in total assets to US$19,584,569 from US$13,354,840.
• Cash and cash equivalents improved to US$10,603,037 from US$7,327,303.
• No impairment recognized on exploration and evaluation assets.

Negative

• Loss for the period of US$3,074,862, higher than the US$2,705,148 loss from the previous year.
• General and administrative expenses rose significantly to US$4,242,520.

Unaudited Condensed Consolidated Interim Financial Statements
For the nine-month period ended November 30, 2022

Notice of No Auditor Review

BRITISH VIRGIN ISLANDS / ACCESSWIRE / January 27, 2023 / These unaudited condensed consolidated interim financial statements of Bradda Head Lithium Limited (the "Company") have not been reviewed by the auditors of the Company.

Condensed Interim Consolidated Statement of Comprehensive Income

for the period ended November 30, 2022

		Nine-month period ended November 30, 2022 (unaudited)	Nine-month period ended November 30, 2021 (unaudited)	Three-month period ended November 30, 2022 (unaudited)	Three-month period ended November 30, 2021 (unaudited)
	Notes	US$	US$	US$	US$
Expenses
General and administrative	2	(4,242,520)	(2,391,522)	(1,690,543)	(764,201)
Share based payment and warrant expense	10	(1,285,743)	(259,816)	(91,539)	(119,726)
Foreign exchange loss		(1,255,343)	(34,338)	(944,005)	(4,197)
		────────	────────	────────	────────
Operating loss		(6,783,606)	(2,685,676)	(2,726,087)	(888,124)
Other income
Warrant fair value re-measurement	11	3,711,264	-	880,920	-
Unrealised (loss) / gain on investment		(2,520)	13,360	-	5,461
		────────	────────	────────	────────
Loss before finance costs		(3,074,862)	(2,672,316)	(1,845,167)	(882,663)
Finance costs		-	(32,832)	-	-
		────────	────────	────────	────────
Loss before income tax		(3,074,862)	(2,705,148)	(1,845,167)	(882,663)
Income tax expense		-	-	-	-
		────────	────────	────────	────────
Loss for the period		(3,074,862)	(2,705,148)	(1,845,167)	(882,663)
		══════	══════	══════	══════
Other comprehensive income - foreign currency translation reserve		-	186	-	-
		────────	────────	────────	────────
Total comprehensive loss for the period		(3,074,862)	(2,704,962)	(1,845,167)	(882,663)
		══════	══════	══════	══════
Basic and diluted loss per share (US cents)	12	(0.81)	(1.50)	(0.49)	(0.49)

The accompanying notes are an integral part of these consolidated interim financial statements.

Condensed Interim Consolidated Statement of Financial Position

as at November 30, 2022

	Notes			November 30, 2022 (unaudited)	February 28, 2022 (audited)
				US$	US$
Non-Current assets
Deferred mining and exploration costs	3			5,911,902	4,183,744
Exploration permits and licences	4			2,255,368	1,549,076
Plant and equipment	8			89,134	54,170
Advances and deposits	6			507,906	88,594
Investment				51,436	53,957
				───────	───────
Total non-current assets				8,815,746	5,929,541
				───────	───────
Current assets
Cash and cash equivalents				10,603,037	7,327,303
Trade and other receivables	6			165,786	97,996
				───────	───────
Total current assets				10,768,823	7,425,299
				───────	───────
Total assets				19,584,569	13,354,840
				═══════	═══════
Equity
Share premium	9			30,467,820	23,434,385
Retained deficit				(12,966,339)	(11,177,220)
				───────	───────
Total equity				17,501,481	12,257,165
				───────	───────
Current liabilities
Trade and other payables	7			1,071,603	1,097,675
Warrant liability	11			1,011,485	-
				───────	───────
Total current liabilities				2,083,088	1,097,675
				───────	───────
Total equity and liabilities				19,584,569	13,354,840
				═══════	═══════

The accompanying notes are an integral part of these consolidated interim financial statements.

These condensed interim consolidated financial statements were approved by the Board of Directors on January 27, 2023 and were signed on their behalf by:

Denham Eke

Director

Condensed Interim Consolidated Statement of Changes in Equity

for the period ended November 30, 2022

		Share premium	Retained deficit	Total
		US$	US$	US$
Balance at March 1, 2022 (audited)		23,434,385	(11,177,220)	12,257,165
Total comprehensive loss for the period
Loss for the period		-	(3,074,862)	(3,074,862)
		──────	───────	───────
Total comprehensive loss for the period		-	(3,074,862)	(3,074,862)
Transactions with owners of the Company
Issue of ordinary shares (note 9 and note 11)		7,581,351	-	7,581,351
Share issue costs capitalised (note 9)		(547,916)	-	(547,916)
Equity settled share-based payments (note 10)		-	1,285,743	1,285,743
		──────	───────	──────
Total transactions with owners of the Company		7,033,435	1,285,743	8,319,178
		──────	───────	──────
Balance at November 30, 2022 (unaudited)		30,467,820	(12,966,339)	17,501,481
		═══════	═══════	═══════

The accompanying notes are an integral part of these consolidated interim financial statements.

Condensed Interim Consolidated Statement of Changes in Equity

for the period ended November 30, 2022 (continued)

		Share premium			Retained deficit		Foreign currency translation reserve		Total
		US$			US$		US$		US$
Balance at March 1, 2021 (audited)		9,443,676			(9,056,687)		186		387,175
Total comprehensive loss for the period
Loss for the period		-			(2,705,148)		-		(2,705,148)
		──────			───────		───────		───────
Total comprehensive loss for the period		-			(2,705,148)		-		(2,705,148)
Transactions with owners of the Company
Issue of ordinary shares (note 8)		11,904,439			-		-		11,904,439
Share issue costs capitalised (note 8)		(413,731)			-		-		(413,731)
Equity settled share-based payments (note 9)		-			259,816		-		259,816
Transfer to retained deficit		-			186		(186)		-
		──────			───────		───────		──────
Total transactions with owners of the Company		11,490,708			260,002		(186)		11,750,524
		──────			───────		───────		──────
Balance at November 30, 2021 (unaudited)		20,934,384			(11,501,833)		-		9,432,551
		═══════			═══════		═══════		═══════

The accompanying notes are an integral part of these consolidated interim financial statements.

Condensed Interim Consolidated Statement of Cash Flows

for the period ended November 30, 2022

	Notes	Nine-month period ended November 30, 2022 (unaudited)	Nine-month period ended November 30, 2021 (unaudited)	Three-month period ended November 30, 2022 (unaudited)	Three-month period ended November 30, 2021 (unaudited)
		US$	US$	US$	US$
Cash flows from operating activities
Loss before income tax		(3,074,862)	(2,705,148)	(1,845,167)	(882,663)
Adjusted for non-cash and non-operating items:
Depreciation	8	23,708	-	9,532	-
Unrealised loss/(gain) on investment		2,520	(13,360)	-	(5,461)
Non-cash interest expense		-	32,832	-	-
Equity settled share based payments expense	10, 11	1,285,743	259,816	91,539	119,726
Warrant fair value re-measurement	11	(3,711,264)	-	(880,920)	-
Unrealised FX adjustment on convertible loan note		-	-	-	-
Unrealised FX on cash balances		1,255,343	(34,338)	944,005	(4,197)
		───────	───────	───────	───────
		(4,218,812)	(2,460,198)	(1,681,011)	(772,595)
Change in trade and other receivables		(487,103)	51,470	(26,609)	255,140
Change in trade and other payables		(26,070)	341,132	717,835	226,133
		───────	───────	───────	───────
Net cash flows used by operating activities		(4,731,985)	(2,067,596)	(989,785)	(291,322)
Cash flows from investing activities
Amounts paid for deferred mining and exploration costs	3	(1,728,158)	(1,121,721)	(1,452,815)	(964,459)
Amounts paid for licences and permits	4	(706,292)	(519,455)	(16,495)	(112,018)
Equipment purchased	8	(58,672)	-	-	-
		───────	───────	───────	───────
Net cash flows used by investing activities		(2,493,122)	(1,641,176)	(1,469,310)	(1,076,477)
Cash flows from financing activities
Short-term loan received		-	60,000	-	-
Cash received from shares and warrants issued	9, 11	12,304,100	9,598,923	-	-
Share issue costs paid	9	(547,916)	(413,731)	-	-
		───────	───────	───────	───────
Net cash flows from financing activities		11,756,184	9,245,192	-	-
		───────	───────	───────	───────
Increase / (decrease) in cash and cash equivalents		4,531,077	5,536,420	(2,459,095)	(1,367,799)
Cash and cash equivalents at beginning of period		7,327,303	86,972	14,006,137	7,021,332
Effect of foreign exchange on cash balances		(1,255,343)	34,338	(944,005)	4,197
		───────	───────	───────	───────
Cash and cash equivalents at end of period		10,603,037	5,657,730	10,603,037	5,657,730
		═══════	═══════	═══════	═══════

The accompanying notes are an integral part of these consolidated interim financial statements.

1 Reporting Entity and basis of preparation

Bradda Head Lithium Limited (the "Company") is a company domiciled in the British Virgin Islands. The address of the Company's registered office is Craigmuir Chambers, Road Town, Tortola, British Virgin Islands. The Company and its subsidiaries together are referred to as the "Group".

The Company is a lithium exploration Group focused on developing its projects in the USA.

These interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting and should be read in conjunction with the last annual consolidated financial statements as at and for the year ended February 28, 2022 ("last annual financial statements"). They do not include all of the information required for a complete set of IFRS financial statements. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last annual financial statements.

The financial information in this report has been prepared in accordance with the Company's accounting policies and in consistency with the last annual financial statements. Full details of the accounting policies adopted by the Company are contained in the financial statements included in the Company's annual report for the year ended February 28, 2022, which is available on the Group's website: www.braddheadltd.com, and on SEDAR at www.sedar.com. These unaudited condensed consolidated interim financial statements should be read in conjunction with the audited Consolidated Financial Statements for the year ended February 28, 2022.

2 General and administrative

The Group's general and administrative expenses include the following:

	Nine-month period ended November 30, 2022 (unaudited) US$	Nine-month period ended November 30, 2021 (unaudited) US$	Three-month period ended November 30, 2022 (unaudited) US$	Three-month period ended November 30, 2021 (unaudited) US$
Auditors' fees	114,508	62,067	13,067	35,466
Directors and management fees and salaries	402,231	310,653	132,955	120,942
Legal and accounting	422,228	510,218	247,291	83,665
Contractor costs	1,979,619	732,407	719,097	280,162
Professional and marketing costs	942,495	535,899	332,928	203,672
Other administrative costs	381,439	240,278	245,205	40,294
	───────	───────	───────	───────
Total	4,242,520	2,391,522	1,690,543	764,201
	═══════	═══════	═══════	═══════

3 Deferred mine exploration costs

The schedule below details the exploration costs capitalised to date:

	Total
	US$
Cost and net book value
At February 28, 2021 (audited)	1,767,274
Capitalised during the year	2,501,853
Disposal under the royalty agreement	(85,383)
	───────
At February 28, 2022 (audited)	4,183,744
	───────
Capitalised during the period	1,728,158
	───────
At November 30, 2022 (unaudited)	5,911,902
	═══════
Cost and net book value
At November 30, 2022 (unaudited)	5,911,902
At February 28, 2022 (audited)	4,183,744
	═══════

The recoverability of the carrying amounts of exploration and evaluation assets is dependent on the successful development and commercial exploitation or sale of the respective area of interest, as well as maintaining the assets in good standing. The Group assessed the DMEC relating to areas for which licenses and permits are held, for impairment as at November 30, 2022. The Board concluded that no facts and circumstances have been identified which suggest the recoverable amount of these assets would not exceed the carrying amount and, as such, no impairment was recognised during the period.

During the year ended February 28, 2022, an impairment charge of US$ Nil was recognised.

4 Exploration permits and licences

The schedule below details the exploration permit and licence costs capitalised to date:

	Total
	US$
Cost and net book value
At February 28, 2021 (audited)	691,465
Capitalised during the year	1,119,455
Disposal under the royalty agreement	(31,614)
Impairment	(230,230)
	───────
At February 28, 2022 (audited)	1,549,076
Capitalised during the period	706,292
	───────
At November 30, 2022 (unaudited)	2,255,368
	═══════
Cost and net book value
At November 30, 2022 (unaudited)	2,255,368
At February 28, 2022 (audited)	1,549,076
	═══════

The Group assessed the carrying amount of the licences and permits held for impairment as at November 30, 2022. The Board concluded that no facts and circumstances have been identified which suggest the recoverable amount of these assets would not exceed the carrying amount and, as such, no impairment was recognised during the period.

During the year ended February 28, 2022, an impairment charge of US$ 230,230 was recognised as a result of project licences and permits that were not renewed.

5 Investment in subsidiary undertakings

As at November 30, 2022 and February 28, 2022, the Group had the following subsidiaries:

Name of company	Place of incorporation	Ownership interest	Principal activity
Bradda Head Limited*	BVI	100%	Holding company of entities below
Zenolith (USA) LLC	USA	100%	Holds USA lithium licences and permits
Verde Grande LLC	USA	100%	Holds USA lithium licences and permits
Gray Wash LLC	USA	100%	Holds USA lithium licences and permits

* Held directly by the Company. All other holdings are indirectly held through Bradda Head Limited

The condensed interim consolidated financial statements include the results of the subsidiaries for the full interim period from March 1, 2022 to November 30, 2022, and up to the date that control ceases.

6 Trade and other receivables and advances and deposits

Non-current

	November 30, 2022 (unaudited)	February 28, 2022 (audited)
	US$	US$
Advances and deposits	507,906	88,594
	══════	══════

Current

	November 30, 2022 (unaudited)	February 28, 2022 (audited)
	US$	US$
Prepayments and other debtors	165,786	97,996
	══════	══════

7 Trade and other payables

	November 30, 2022 (unaudited)	February 28, 2022 (audited)
	US$	US$
Trade payables	950,402	1,019,175
Accrued expenses and other payables	121,201	78,500
	──────	──────
	1,071,603	1,097,675
	══════	══════

8 Plant and equipment

	Motor vehicle	Total
Cost	US$	US$
As at March 1, 2021 (audited)	-	-
Additions during the year	55,718	55,718
	──────	──────
As at February 28, 2022 (audited)	55,718	55,718
Additions during the period	58,672	58,672
	──────	──────
As at November 30, 2022 (unaudited)	114,390	114,390
	══════	══════

8 Plant and equipment (continued)

	Motor vehicle	Total
Accumulated depreciation	US$	US$
As at March 1, 2021 (audited)	-	-
Depreciation charge for the year	(1,548)	(1,548)
	──────	──────
As at February 28, 2022 (audited)	(1,548)	(1,548)
Depreciation charge for the period	(23,708)	(23,708)
	──────	──────
As at November 30, 2022 (unaudited)	(25,256)	(25,256)
	══════	══════
Carrying amount
As at November 30, 2022 (unaudited)	89,134	89,134
As at February 28, 2022 (audited)	54,170	54,170
	══════	══════

9 Share premium

Authorised

The Company is authorised to issue an unlimited number of nil par value shares of a single class.

	Shares		Share capital	Share premium
Issued ordinary shares of US$0.00 each			US$	US$
At February 28, 2021 (audited)		75,040,282	-	9,443,676
		═══════	═══════	═══════
Shares issued for cash	158,499,941		-	12,098,924
Shares issued to settle loans	48,618,529		-	2,159,722
Shares issued in lieu of Directors fees	3,037,362		-	145,794
Shares issued to Zenith Minerals Limited *	32,217,765			-
Share issue costs capitalised	-		-	(413,731)
		───────	───────	───────
At February 28, 2022 (audited)		317,413,879	-	23,434,385
	═══════		═══════	═══════
Shares issued for cash (note 11)	73,195,560		-	7,581,351
Share issue costs capitalised	-		-	(547,916)
	───────		───────	───────
At November 30, 2022 (unaudited)	390,609,439		-	30,467,820
	═══════		═══════	═══════
* In line with the agreement entered into with Zenith Minerals Limited ("Zenith"), shares were issued to Zenith to maintain their shareholding at 15%. Following the listing of the Company's shares on AIM in July 2021, the anti-dilution protection held by Zenith no longer applies to any new issues of shares.

10 Equity settled share based payments

The cost of equity settled transactions with certain Directors of the Company and other participants ("Participants") is measured by reference to the fair value at the date on which they are granted. The fair value is determined based on the Black-Scholes option pricing model.

During the nine-month period ended November 30, 2022, outstanding fees due to directors totaling US$ Nil were settled by the issue of shares (28 February 2022: US$Nil)

Options and warrants

The total number of share options and warrants in issue as at the period end is set out below.

Recipient	Grant Date			Term in years		Exercise Price	Number at March 1, 2022 (audited)		Number Issued		Number Lapsed/ cancelled/expired		Number Exercised		Number at November 30, 2022 (unaudited)		Fair value
Options																	US$
Directors and Participants	April 2018			5		US$ 0.15668	1,606,304		-		-		-		1,606,304		24,028
Directors and Participants	June 2021			5		US$ 0.048	18,000,000		-		-		-		18,000,000		1,110,556
Directors and Participants	September 2021			5		£0.09	4,000,000		-		-		-		4,000,000		314,962
Directors and Participants	April 2022			5		£0.18	-		9,200,000		-		-		9,200,000		1,122,876
Warrants
Supplier warrants		July 2021			5	£0.0550		1,818,182		-		-		-		1,818,182		124,482
Supplier warrants		July 2021			3	£0.0825		2,254,545		-		-		-		2,254,545		8,275
Shareholder warrants		December 2021			2	£0.0885		1,185,687		-		-		-		1,185,687		44,858
Supplier warrants		April 2022			2	£0.1350		-		3,244,331		-		-		3,244,331		284,918
							───────		───────		───────		───────		───────		───────
							28,864,718		12,444,331		-		-		41,309,049		3,034,955
							═══════		═══════		═══════		═══════		═══════		═══════

10 Equity settled share based payments (continued)

The amount expensed in the income statement has been calculated by reference to the fair value at the grant date of the equity instrument and the estimated number of equity instruments to vest after the vesting period.

	Nine-month period ended November 30, 2022 (unaudited) US$	Nine-month period ended November 30, 2021 (unaudited) US$	Three-month period ended November 30, 2022 (unaudited) US$	Three-month period ended November 30, 2021 (unaudited) US$
Share based payments charge	1,285,743	259,816	91,539	-
	═══════	═══════	═══════	═══════

The inputs used in the measurement of the fair values at grant date of the equity-settled share-based payment plans issued during the period are as follows:

April 2022 options

	Award date and exercise price
Fair value at grant date	£0.09308
Exercise price	£0.180
Weight average expected volatility	81.90%
Weighted average expected life (years)	5
Risk-free interest rate (based on comparable companies)	1.52%

Terms of the issued options are as follows:

- 9,200,000 options have been granted and are subject to the three independent vesting conditions for 1/3 of the entitlement, relating to the successful fund raising in respect of the Group's operational budget, commencement of a drilling program in respect of the San Domingo project and resolution of certain Wickieup project title claims. All un-exercised options expire after a period of 5 years from grant date. It is assumed that options are exercised within 5 years from date of grant. The applied volatility is based on historical volatility.

April 2022 supplier warrants

	Award date and exercise price
Fair value at grant date	£0.06697
Exercise price	£0.135
Weight average expected volatility	81.90%
Weighted average expected life (years)	2
Risk-free interest rate (based on comparable companies)	0.80%

Terms of the issued warrants are as follows:

- As part of the fundraise completed during April 2022, certain service providers of the Company received warrants for services rendered. As a result, 3,244,331 warrants have been issued. All un-exercised warrants expire after a period of 2 years from grant date. It is assumed that warrants are exercised within 2 years from date of grant. The applied volatility is based on historical volatility.

11 Warrants

The cost of equity warrants granted during the period are measured by reference to the fair value at the date on which they are granted. The fair value is determined based on the Black-Scholes option pricing model.

During the nine-month period ended November 30, 2022, the Company awarded warrants to investors who participated in the fundraise completed during April 2022.

The total number of warrants in issue as at the period end is set out below.

Recipient	Grant Date	Term in years	Exercise Price	Warrants at March 1, 2022 (audited)	Number of Warrants Issued	Number of Warrants Lapsed/ cancelled/expired	Number of Warrants Exercised	Number of Warrants at November 30, 2022 (unaudited)	Fair value
Warrants									US$
Shareholder warrants	April 2022	2	£0.2100	-	73,195,560	-	-	73,195,560	1,011,485
				───────	───────	───────	───────	───────	───────
				-	73,195,560	-	-	73,195,560	1,011,485
				═══════	═══════	═══════	═══════	═══════	═══════

The fair value applied to the shareholder warrants has been classified as a financial liability. At period end, the warrant liability has been re-measured to fair value, with a corresponding entry to profit and loss of US$ 3,711,264 (period ended November 30, 2021: Nil) within Warrant Fair Value Re-Measurement.

Reconciliation of warrant liability fair value:

	Fair value
	US$
Balance at March 1, 2022	-
Warrants issued during the period	4,722,749
Fair value re-measurement	(3,711,264)
	───────
Balance at November 30, 2022	1,011,485
	═══════

11 Warrants (continued)

April 2022 shareholder warrants

Grant date fair value	Award date and exercise price
Fair value at grant date	£0.0492
Exercise price	£0.21
Weight average expected volatility	81.90%
Weighted average expected life (years)	2
Risk-free interest rate (based on comparable companies)	0.80%

November 30, 2022 fair value	Award date and exercise price
Fair value	£0.0118
Exercise price	£0.21
Weighted average expected volatility	80.5%
Weighted average expected life remaining (years)	1.39
Risk-free interest rate (based on comparable companies)	4.38%

As part of the fundraise completed during April 2022, all participating shareholders received a warrant on 1:1 basis for shares acquired. As a result, 73,195,560 warrants have been issued. All un-exercised warrants expire after a period of 2 years from grant date. It is assumed that warrants are exercised within 2 years from date of grant. The applied volatility is based on historical volatility.

12 Basic and diluted loss per share

The calculation of basic profit per share of the Company is based on the loss for the period of US$ 3,074,862 (nine-month period to November 30, 2021: loss of US$ 2,052,489) and the weighted average number of shares of 379,122,544 (at November 30, 2021: 147,618,936) in issue during the period.

Diluted loss per share is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares such as warrants and options. An adjustment for the dilutive effect of share options and warrants in the current period has not been reflected in the calculation of the diluted loss per share, as the effect would have been anti-dilutive, due the Company recognising a loss for the period.

13 Related party transactions and balances

Edgewater Associates Limited ("Edgewater")

During the nine-month period ended November 30, 2022, Directors' and Officers' insurance was obtained on an arms-length basis through Edgewater, which is a 100% subsidiary of Manx Financial Group ("MFG"). James Mellon and Denham Eke are Directors of both the Company and MFG.

During the period, the premium payable on the policy was US$ 49,318 (year ended February 28, 2022: US$ 44,303), of which US$ 32,122 was prepaid as at the period end (February 28, 2022: US$ 11,076).

14 Commitments and contingent liabilities

The Group has certain obligations to expend minimum amounts on exploration works on mining tenements in order to retain an interest in them, equating to approximately US$ 415,454 during the next 12 months. This includes annual fees in respect of licence renewals. These obligations may be varied from time to time, subject to approval and are expected to be filled in the normal course of exploration and development activities of the Company.

15 Events after the reporting date

On 21 December 2022, the Company awarded 500,000 ordinary share options each to Euan Jenkins and Alex Borrelli, independent non-executive directors of the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Bradda Head Lithium Limited

View source version on accesswire.com:
https://www.accesswire.com/737037/Bradda-Head-Lithium-Ltd-Announces-Unaudited-Interim-Financial-Statements

FAQ

What was Bradda Head Lithium's loss for the nine-month period ended November 30, 2022?

Bradda Head Lithium reported a loss of US$3,074,862 for the nine-month period ended November 30, 2022.

How did total assets change for Bradda Head Lithium by November 30, 2022?

Total assets increased to US$19,584,569 from US$13,354,840.

What are the general and administrative expenses for Bradda Head Lithium during the nine months ending November 30, 2022?

General and administrative expenses totaled US$4,242,520.

How many warrants did Bradda Head Lithium issue during the period?

Bradda Head Lithium issued 73,195,560 warrants during the nine-month period ended November 30, 2022.

What was the cash position of Bradda Head Lithium at the end of November 2022?

The company had cash and cash equivalents of US$10,603,037.